These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 17199862)

  • 41. Metabolic abnormalities associated with calyceal diverticular stones.
    Auge BK; Maloney ME; Mathias BJ; Pietrow PK; Preminger GM
    BJU Int; 2006 May; 97(5):1053-6. PubMed ID: 16643491
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bone mineral density and urine calcium excretion among subjects with and without nephrolithiasis.
    Asplin JR; Bauer KA; Kinder J; Müller G; Coe BJ; Parks JH; Coe FL
    Kidney Int; 2003 Feb; 63(2):662-9. PubMed ID: 12631132
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genetic hypercalciuric stone-forming rats.
    Bushinsky DA; Frick KK; Nehrke K
    Curr Opin Nephrol Hypertens; 2006 Jul; 15(4):403-18. PubMed ID: 16775455
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antialbuminuric actions of calcilytics in the remnant kidney.
    Takenaka T; Inoue T; Miyazaki T; Nishiyama A; Ishii N; Hayashi M; Suzuki H
    Am J Physiol Renal Physiol; 2015 Aug; 309(3):F216-26. PubMed ID: 26017971
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of takusha, a kampo medicine, on renal stone formation and osteopontin expression in a rat urolithiasis model.
    Yasui T; Fujita K; Sato M; Sugimoto M; Iguchi M; Nomura S; Kohri K
    Urol Res; 1999 Jun; 27(3):194-9. PubMed ID: 10422821
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of vitamin D₃ overdose and calcium supplementation in experimental nephrolithiasis model.
    Ramos MF; de Santana LG; Rasvickas CV; Teixeira Vde P; Schor N
    J Bras Nefrol; 2014; 36(2):132-8. PubMed ID: 25055352
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Influence of nifedipine on stone formation and renal function in cholesterol-induced nephrolithiasis in rats.
    Strohmaier WL; Witte B; Nelde HJ
    Urol Int; 1994; 52(2):87-92. PubMed ID: 8178383
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Calcium and vitamin D have a synergistic role in a rat model of kidney stone disease.
    Letavernier E; Verrier C; Goussard F; Perez J; Huguet L; Haymann JP; Baud L; Bazin D; Daudon M
    Kidney Int; 2016 Oct; 90(4):809-17. PubMed ID: 27475231
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sodium-phosphate cotransporters, nephrolithiasis and bone demineralization.
    Prié D; Beck L; Friedlander G; Silve C
    Curr Opin Nephrol Hypertens; 2004 Nov; 13(6):675-81. PubMed ID: 15483460
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Contribution of diet to the dosing time-dependent change of vitamin D3-induced hypercalcemia in rats.
    Tsuruoka S; Sugimoto K; Fujimura A
    Life Sci; 2000 Dec; 68(5):579-89. PubMed ID: 11197755
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hypercalciuria associated with long-term administration of calcitriol (1,25-dihydroxyvitamin D3). Action of hydrochlorothiazide.
    Santos F; Smith MJ; Chan JC
    Am J Dis Child; 1986 Feb; 140(2):139-42. PubMed ID: 3753816
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Increased propensity for calcium phosphate kidney stones with topiramate use.
    Vega D; Maalouf NM; Sakhaee K
    Expert Opin Drug Saf; 2007 Sep; 6(5):547-57. PubMed ID: 17877442
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An investigation into the role of ascorbic acid in renal calculogenesis in albino rats.
    Singh PP; Sharma DC; Rathore V; Surana SS
    J Urol; 1988 Jan; 139(1):156-7. PubMed ID: 3336088
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Re: Persistence of 1,25D-induced hypercalciuria in alendronate treated genetic hypercalciuric stone-forming rats fed a low calcium diet.
    Assimos DG
    J Urol; 2014 Aug; 192(2):615. PubMed ID: 25035042
    [No Abstract]   [Full Text] [Related]  

  • 55. Serum sclerostin is associated with recurrent kidney stone formation independent of hypercalciuria.
    Rodríguez D; Gurevich E; Mohammadi Jouabadi S; Pastor Arroyo EM; Ritter A; Estoppey Younes S; Wagner CA; Imenez Silva PH; Seeger H; Mohebbi N
    Clin Kidney J; 2024 Jan; 17(1):sfad256. PubMed ID: 38186870
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reduction of vitamin D induced stone formation by calcium.
    Strohmaier WL; Seeger RD; Osswald H; Bichler KH
    Urol Res; 1994; 22(5):301-3. PubMed ID: 7879315
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A different perspective on the filtration barrier after kidney stone formation: An immunohistochemical and biochemical study.
    Karabulut D; Kaymak E; Yalçin B; Ulger H; Keti DB
    Urolithiasis; 2021 Jun; 49(3):201-210. PubMed ID: 33155094
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Vitamin D and urinary stone disease: the current state of problem].
    Ali HM; Saenko VS; Pesegov SV; Ali SH; Vovdenko SV; Kazilov YB
    Urologiia; 2018 Dec; (5):122-127. PubMed ID: 30575362
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Preliminary study of the role of nanobacteria in the formation of renal stones in experimental rats and its mechanism.
    Yang H; Cheng X; Chen Y; Zeng Z; Wang G
    Arch Med Sci Atheroscler Dis; 2024; 9():e1-e15. PubMed ID: 38434940
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of calcitriol administration on calcium metabolism healthy men.
    Adams ND; Gray RW; Lemann J; Cheung HS
    Kidney Int; 1982 Jan; 21(1):90-7. PubMed ID: 6896223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.